Infertility Solutions P. C.'s most recent IVF pregnancy data

(data compiled 1/8/2007)

We participate in national reporting of IVF data as administered by the Center for Disease Control (CDC) and the American Society of Reproductive Medicine's Society for Advanced Reproductive Technologies (SART). This nationally collected database can be reviewed at www.cdc.gov/art. One of the shortcomings of this data is that it may be up to two years old. This is because it is reported on an annual basis and the data has to wait for all babies to be born who were conceived in the prior calendar year. Much can change in a program in that time period including personnel, procedures and equipment.

Our laboratory was completely redesigned to take advantage of newly available state-of-the-art technologies at the beginning of 2003. We have also changed our approach to laboratory personnel to try to capture the advantages of both small and large programs by supplementing our embryology staff with ongoing outside embryologists. For example, Dr. Lynette Scott and Joe Sokoloski have served in this capacity.

The availability of the internet makes it possible to present more up-to-date information about our program. This information can be used with the CDC/SART data to make an informed decision about program selection. We present ongoing pregnancy results with information about the patients but with identifying details removed.

Summary data is expressed in terms of pregnancy rate per IVF embryo transfer. Most of the time embryos are produced during an IVF cycle, but the problem is to get them to implant and become babies. Three types pregnancies are highlighted- biochemical (positive pregnancy test), clinical (tissue or ultrasound evidence of pregnancy including tubal pregnancies), and ongoing/delivered (the pregnancies delivered or with a high probability of delivering). These three types of pregnancy rates provide diffent kinds of information. The ongoing/delivered pregnancy rate provides the most useful prognostic information for patients considering a program. The clinical pregnancy rate is more a reflection of the laboratory competence of the program since many pregnancy losses of clinical pregnancies reflect patient characteristics (e.g., ectopic pregnancy). Biochemical pregnancy rate reflect in part the efficacy of the embryo transfer procedure aas well as chomomsomal abnomality of the embryos transferred. The summary data for women under age 35 is emphasized, because less patient selection takes place in this age category. Our program does not reject informed patients on the basis of age or decreased ovarian reserve (elevated FSH levels). This may adversely effect our pregnancy rates compared to programs which do select patients, but we have had many wonderful pregnancies in patients rejected by other programs.

Time period: Embryo tranfer between February 1, 2006 through December 31, 2006

Age.................Problem.............................Outcome

26.......................PCO and male factor.....................clinical pregnancy

27.......................endometriosis and tubal.................biochemical pregnancy

28.......................male

28.......................male..............................................biochemical pregnancy

29.......................unexplained...................................ongoing pregnancy

29.......................endometriosis and PCO................biochemical pregnancy

29.......................endometriosis and PCO................ongoing pregnancy

29.......................endometriosis................................biochemical pregnancy

30.......................PCO.............................................ongoing pregnancy

30.......................PCO

30.......................decreased ovarian reserve..............ongoing pregnancy

31.......................PCO

31.......................PCO...............................................clinical pregnancy

31.......................endometriosis and PCO................ongoing pregnancy

31.......................endometriosis and tubal

31.......................ovarian reserve..............................ongoing pregnancy

32.......................ovarian reserve

32.......................PCO...............................................ongoing pregnancy

32.......................PCO and male factor

32.......................unexplained....................................biochemical pregnancy

33.......................PCO

33.......................PCO..............................................ongoing pregnancy

33.......................ovarian reserve

33.......................ovarian reserve..............................ongoing pregnancy

34.......................male factor and PCO.....................clinical pregnancy

34.......................unexplained

34.......................unexplained...................................ongoing pregnancy

34........................male factor...................................ongoing pregnancy

34.......................male factor and PCO

35.......................PCO and tubal

35.......................PCO..............................................biochemical pregnancy

35........................male factor...................................ongoing pregnancy

36.......................tubal factor

36.......................endometriosis, tubal, and PCO

36.......................PCO..............................................ongoing pregnancy

36.......................unexplained....................................clinical pregnancy

36.......................tubal and uterine factor

36.......................tubal and uterine factor....................ongoing pregnancy

36.......................male factor and PCO.......................ongoing pregnancy

37.......................unexplained

37.......................PCO................................................biochemical pregnancy

37.......................tubal and male factor.......................clinical pregnancy

37.......................male factor

37.......................male factor and ovarian reserve.......ongoing pregnancy

37.......................PCO, tubal and male factor

37........................male and tubal factor

38........................tubal and decreased ovarian reserve

38........................endometriosis and tubal factor

38........................decreased ovarian reserve................biochemical pregnancy

38.......................PCO

38.......................male and tubal factor

38.......................male and tubal factor.........................ongoing pregnancy

38........................male factor

39.......................PCO and tubal factor.........................ongoing pregnancy

39.......................ovarian reserve

39.......................ovarian reserve...................................biochemical pregnancy

39.......................unexplained.......................................ongoing pregnancy

39.......................male factor.........................................ongoing pregnancy

39.......................tubal factor

39.......................male factor........................................ongoing pregnancy

39.......................ovarian reserve and tubal factor.........ongoing pregnancy

39........................endometriosis and tubal factor

40.......................ovarian reserve

40.......................male factor........................................clinical pregnancy

41.......................male factor

41.......................male factor and ovarian reserve

42.......................tubal....................................................clinical pregancy

43.......................unexplained

44.......................decreased ovarian reserve

46.......................male factor and ovarian reserve

Summary data for fresh IVF (patients under age 35) for the year 2006 to date*:

Biochemical pregnancies/IVF transfers- 13/19 or 68.4%

Clinical pregnancies/IVF transfers- 10/19 or 52.6%

Ongoing or delivered pregnancies/IVF transfers- 8/19 or 42.1%

Summary data for fresh IVF (patients under age 43) for the year 2006 to date*:

Clinical pregnancies/IVF transfers- 18/42 or 42.9%

Ongoing or delivered pregnancies/IVF transfers- 14/42 or 33.3%

Summary data for fresh IVF (patients under age 35) for the year 2005 * +:

Biochemical pregnancies/IVF transfers- 30/41 or 73.2%

Clinical pregnancies/IVF transfers- 22/41 or 53.7%

Ongoing or delivered pregnancies/IVF transfers- 13/41 or 31.7%

Summary data for fresh IVF (patients under age 43) for the year 2005 * +:

Clinical pregnancies/IVF transfers- 38/75 or 50.7%

Ongoing or delivered pregnancies/IVF transfers- 24/75 or 32%

*If using donor eggs, the age of the donor is used.

+2005 data is for 13 months

Summary data for fresh IVF (patients under age 35) for the years 2003 through 2005**:

Clinical pregnancies/IVF transfers- 49.5%

Delivered pregnancies/IVF transfers- 34.7%

**Data in the above format is available by request

2005 data